Mutares Navigates Debt and Deals After €105 Million Equity Injection

Fresh capital is in hand, but the road ahead for Mutares is paved with both ambitious acquisition plans and immediate balance sheet repairs. The German holding company successfully concluded its rights issue, raising approximately €105 million, yet its shares continue to languish near a 52-week low of EUR 24.80, barely above the EUR 24.50 subscription price.

The capital raise, which saw a strong 96% take-up from existing shareholders, is earmarked for a strategic push into North America. Roughly 80% of the proceeds are reserved for acquisitions there, where Mutares has identified a pipeline of potential targets with combined sales of around €4.8 billion. The company anticipates higher exit multiples in the US market compared to Europe and is planning to establish a second operational site there alongside its existing Chicago base.

Simultaneously, management is confronting a covenant issue within its bond terms. The company anticipates a breach of its net debt-to-equity covenant, attributed to valuation effects, fewer equity-positive transactions in Q4, and increased leasing liabilities. In response, Mutares plans an aggressive bond buyback program, aiming to repurchase at least €25 million per quarter of its 2023/2027 bond starting in Q2. The goal is to reduce total bond volume to between EUR 250 million and EUR 300 million by the end of 2026 and return to covenant compliance by the close of the second quarter.

This financial maneuvering unfolds against a backdrop of active portfolio restructuring. The sale of inTime Group is complete, while processes for divesting Peugeot Motocycles and Polish bus manufacturer Relobus are underway. On the acquisition side, Mutares is set to take over two business units from Magna: its European lighting operations and its Car-Top-Systems division. These deals, with a combined revenue volume of approximately $320 million, are expected to close in the second quarter of 2026.

Should investors sell immediately? Or is it worth buying Mutares?

The company’s full 2025 report, due April 28, will provide a clearer picture of the starting point. Preliminary figures show the holding company’s net income rose to EUR 130.4 million, with group sales climbing to EUR 6.5 billion. For 2026, Mutares is targeting consolidated sales between EUR 7.9 billion and EUR 9.1 billion and holding net income of EUR 165 million to EUR 200 million. Its medium-term ambition through 2030 is for 25% annual growth in both revenue and profit.

The capital increase has slightly diluted the stake of the founding consortium around CEO Robin Laik, reducing its voting rights from just over 25% to just under 24%. This shift was passive, with no shares sold by the founding family.

Despite the stock’s weak performance—down about 17% year-to-date and trading over 15% below its 200-day moving average—analysts maintain a bullish outlook. Warburg Research reaffirms a buy rating with a EUR 46.00 price target, while Jefferies sees fair value at EUR 37.00. Based on market estimates, analysts project a dividend of around EUR 2.09 per share for the 2025 financial year, a topic likely to be finalized at the annual general meeting on July 3. Investors will next receive an update with the Q1 2026 report on May 12.